title: Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2.
abstract: Radiotherapy combined with chemotherapy is the treatment of choice for glioblastoma and locally advanced lung cancer, but radioresistance of these two types of cancer remains a significant therapeutic hindrance. To identify molecular target(s) for radiosensitization, we screened a small interfering RNA (siRNA) library targeting all protein kinases and E3 ubiquitin ligases in the human genome and identified tumor necrosis factor receptor-associated factor 2 (TRAF2). Silencing of TRAF2 using siRNA caused a significant growth suppression of glioblastoma U251 cells and moderately sensitized these radioresistant cells to radiation. Overexpression of a really interesting new gene (RING)-deleted dominant-negative TRAF2 mutant also conferred radiosensitivity, whereas overexpression of wild-type (WT) TRAF2 significantly protected cells from radiation-induced killing. Likewise, siRNA silencing of TRAF2 in radioresistant lung cancer H1299 cells caused growth suppression and radiosensitization, whereas overexpression of WT TRAF2 enhanced radioresistance in a RING ligase-dependent manner. Moreover, siRNA silencing of TRAF2 in UM-SCC-1 head and neck cancer cells also conferred radiosensitization. Further support for the role of TRAF2 in cancer comes from the observations that TRAF2 is overexpressed in both lung adenocarcinoma tissues and multiple lung cancer cell lines. Importantly, TRAF2 expression was very low in normal bronchial epithelial NL20 cells, and TRAF2 silencing had a minimal effect on NL20 growth and radiation sensitivity. Mechanistically, TRAF2 silencing blocks the activation of the nuclear factor-kappaB signaling pathway and down-regulates several G(2)-M cell cycle control proteins, resulting in enhanced G(2)-M arrest, growth suppression, and radiosensitization. Our studies suggest that TRAF2 is an attractive drug target for anticancer therapy and radiosensitization.
authors.affiliation: Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109-5637, USA.
authors.forename: Min
authors.initials: M
authors.lastname: Zheng
authors.forename: Susan E
authors.initials: SE
authors.lastname: Morgan-Lappe
authors.forename: Jie
authors.initials: J
authors.lastname: Yang
authors.forename: Katrina M
authors.initials: KM
authors.lastname: Bockbrader
authors.forename: Deepika
authors.initials: D
authors.lastname: Pamarthy
authors.forename: Dafydd
authors.initials: D
authors.lastname: Thomas
authors.forename: Stephen W
authors.initials: SW
authors.lastname: Fesik
authors.forename: Yi
authors.initials: Y
authors.lastname: Sun
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000235:genetics / Q000528:radiation effects; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics / Q000378:metabolism / Q000532:radiotherapy / Q000628:therapy*; D018797:Cell Cycle Proteins / Q000378:metabolism; D002455:Cell Division / Q000235:genetics / Q000528:radiation effects; D048708:Cell Growth Processes / Q000235:genetics; D045744:Cell Line, Tumor; D016195:G2 Phase / Q000235:genetics / Q000528:radiation effects; D020868:Gene Silencing; D005909:Glioblastoma / Q000235:genetics / Q000378:metabolism / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D020672:I-kappa B Proteins / Q000378:metabolism; D008175:Lung Neoplasms / Q000235:genetics / Q000378:metabolism / Q000532:radiotherapy / Q000628:therapy*; D051379:Mice; D000072000:NF-KappaB Inhibitor alpha; D016328:NF-kappa B / Q000378:metabolism; D028861:Nuclear Pore Complex Proteins / Q000378:metabolism; D034741:RNA, Small Interfering / Q000235:genetics*; D016601:RNA-Binding Proteins / Q000378:metabolism; D011836:Radiation Tolerance / Q000235:genetics; D047992:TNF Receptor-Associated Factor 2 / Q000235:genetics*
chemical_list: C119724:AGFG1 protein, human; D018797:Cell Cycle Proteins; D020672:I-kappa B Proteins; D016328:NF-kappa B; C000606204:NFKBIA protein, human; C000606205:Nfkbia protein, mouse; D028861:Nuclear Pore Complex Proteins; D034741:RNA, Small Interfering; D016601:RNA-Binding Proteins; D047992:TNF Receptor-Associated Factor 2; D000072000:NF-KappaB Inhibitor alpha
references.citation: Assay Drug Dev Technol. 2003 Feb;1(1 Pt 2):175-80
references.pmid: 15090144
references.citation: FASEB J. 2005 Apr;19(6):620-2
references.pmid: 15670977
references.citation: Oncogene. 2004 Sep 16;23(42):7047-52
references.pmid: 15258565
references.citation: Cell. 1995 Dec 29;83(7):1243-52
references.pmid: 8548810
references.citation: J Cell Sci. 2002 Feb 15;115(Pt 4):679-88
references.pmid: 11865024
references.citation: Am J Pathol. 2003 Apr;162(4):1151-62
references.pmid: 12651607
references.citation: J Biomol Screen. 1999;4(2):67-73
references.pmid: 10838414
references.citation: Cell. 1996 Jan 26;84(2):299-308
references.pmid: 8565075
references.citation: Oncogene. 2005 Nov 10;24(49):7381-8
references.pmid: 16044155
references.citation: J Immunol. 1999 Apr 15;162(8):4447-54
references.pmid: 10201981
references.citation: Genes Dev. 1998 Sep 15;12(18):2821-30
references.pmid: 9744859
references.citation: Oncogene. 2008 May 22;27(23):3244-55
references.pmid: 18084327
references.citation: Genes Dev. 1993 Nov;7(11):2064-70
references.pmid: 8224838
references.citation: J Clin Invest. 1991 Aug;88(2):691-5
references.pmid: 1864978
references.citation: Drug Resist Updat. 2007 Aug-Oct;10(4-5):162-81
references.pmid: 17669681
references.citation: Am J Respir Crit Care Med. 2005 Sep 1;172(5):523-9
references.pmid: 15961694
references.citation: Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):927-31
references.pmid: 14967452
references.citation: Cancer Biol Ther. 2003 Nov-Dec;2(6):623-9
references.pmid: 14688465
references.citation: Immunity. 1997 Nov;7(5):715-25
references.pmid: 9390694
references.citation: Int J Cancer. 2001 Oct 1;94(1):1-5
references.pmid: 11668471
references.citation: Immunity. 1997 Nov;7(5):703-13
references.pmid: 9390693
references.citation: Cancer Res. 2001 May 15;61(10):3986-97
references.pmid: 11358816
references.citation: Sci STKE. 2005 Feb 22;2005(272):pe7
references.pmid: 15728425
references.citation: Mol Biol Cell. 2002 Jun;13(6):1929-39
references.pmid: 12058060
references.citation: Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5742-6
references.pmid: 8516323
references.citation: Cancer Res. 2001 Nov 15;61(22):8211-7
references.pmid: 11719452
references.citation: EMBO J. 2004 Jan 28;23(2):322-32
references.pmid: 14713952
references.citation: Cancer Metastasis Rev. 2004 Aug-Dec;23(3-4):209-25
references.pmid: 15197324
references.citation: Radiat Res. 2002 Mar;157(3):322-30
references.pmid: 11839095
references.citation: Oncogene. 2001 Apr 26;20(18):2243-53
references.pmid: 11402319
references.citation: Nat Med. 2002 Aug;8(8):816-24
references.pmid: 12118244
references.citation: Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14453-8
references.pmid: 9826721
references.citation: Nat Rev Cancer. 2007 Nov;7(11):861-9
references.pmid: 17943134
references.citation: J Biochem Mol Biol. 2002 Jan 31;35(1):61-6
references.pmid: 16248971
references.citation: Oncogene. 2007 Apr 26;26(19):2707-16
references.pmid: 17057733
references.citation: Mol Biol Cell. 2002 Oct;13(10):3431-40
references.pmid: 12388747
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: Br J Cancer. 2008 Feb 12;98(3):523-8
references.pmid: 18231106
references.citation: Nature. 2006 May 25;441(7092):431-6
references.pmid: 16724054
references.citation: Nature. 2001 Aug 23;412(6849):822-6
references.pmid: 11518967
references.citation: Cancer Res. 2007 May 1;67(9):4390-8
references.pmid: 17483353
references.citation: Genes Dev. 2001 Jun 1;15(11):1311-33
references.pmid: 11390353
references.citation: Oncogene. 2001 Oct 1;20(44):6482-91
references.pmid: 11607847
references.citation: Mol Cancer Ther. 2006 Mar;5(3):637-44
references.pmid: 16546978
references.citation: Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13784-9
references.pmid: 11707590
references.citation: Science. 1998 Sep 11;281(5383):1680-3
references.pmid: 9733516
references.citation: Acta Neurochir Suppl. 2003;88:37-43
references.pmid: 14531559
references.citation: Neoplasia. 2006 Aug;8(8):645-54
references.pmid: 16925947
references.citation: Semin Oncol. 2004 Oct;31(5):635-44
references.pmid: 15497116